Label Image (Lbl500903409)
Losartan Potassium
Product Images NDC 50090-3409
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-3409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Losartan Fig1)
There are two treatments being compared, Atenolol and Losartan Potassium, with the primary endpoint being unknown. An adjusted risk reduction of 13%, with a p-value of 0.021, is mentioned. The table below shows study month increments of every 6 months.*
Figure 2 (Losartan Fig2)
Figure 3 (Losartan Fig3)
The text is not meaningful and seems to be a mix of random characters and symbols. It is not available.*
Figure-4 (Losartan Fig4)
The text displays information about the results of a clinical trial testing a drug called Losttan Potassium compared to a placebo. The table shows the percentage of patients who experienced an event during the trial, with 60% of patients on Losttan Potassium experiencing an event compared to 40% on the placebo. The risk reduction is noted as 16.1%, with a significance level of p=0.022.*
Chemical Structure (Losartan Str)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
